福光股份(688010.SH):作為戰略投資者 向星雲大數據增資3368.726萬元
格隆匯 8 月 11日丨福光股份(688010.SH)公佈,公司於2020年8月10日與福建省電子信息(集團)有限責任公司、星雲大數據及其他增資參與方共同簽署《關於福建省星雲大數據應用服務有限公司增資擴股協議》。
公司作為此次星雲大數據增資擴股項目的戰略投資者向星雲大數據增資3368.726萬元,認購星雲大數據新增註冊資本2041.6521萬元,入股價格為1.65元/股,佔增資擴股後星雲大數據8%股權。此次星雲大數據增資擴股項目的其他增資參與方入股價格均為1.65元/股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.